|
|
|
News 2009:
November 24, 2009
|
|
BioTime, Inc. Announces Third Quarter 2009 Financial Results and Update on Recent Developments
|
October 22, 2009
|
|
BioTime, Inc. Announces Approval For NYSE Amex Listing... Trading will begin on Friday
|
October 22, 2009
|
|
Chief Medical Officer of BioTime's Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China
|
October 15, 2009
|
|
New BioTime Subsidiary, OncoCyte Corporation, Receives $2 Million Equity Financing to Develop Cancer Treatments Using Stem Cell Technology
|
September 24, 2009
|
|
BioTime, Inc. Presentation at 2009 World Stem Cell Summit
|
September 23, 2009
|
|
BioTime, Inc. to Form Asian Subsidiary Enters Into Agreements With Dr. Lu Daopei and Nanshan Memorial Medical Institute Limited
|
September 18, 2009
|
|
BioTime CEO Dr. Michael West to Present Keynote Address at China-USA Scientific Forum of Stem
Cell and Regenerative Medicine
|
September 2, 2009
|
|
BioTime CEO Dr. Michael West to Present at 2009 World Stem Cell Summit |
August 24, 2009
|
|
BioTime, Inc. Completes Exchange Offer for Revolving Line of Credit Notes |
August 10, 2009
|
|
BioTime Appoints Walter Funk Vice President for Stem Cell Research
|
| August 5, 2009 |
|
BioTime, Inc. Commences Exchange Offer for Revolving Line of Credit Notes
|
July 13, 2009
|
|
BioTime Investors Fund Second $4,000,000 Equity Tranche |
July 9, 2009
|
|
BioTime Announces Stem Cell Co-marketing Agreement with Millipore, Millipore to Distribute BioTime's Novel ACTCellerate£ Human Progenitor Cells |
July 7, 2009
|
|
BioTime, Inc. Adds New Members to Its Board of Directors |
May 11, 2009
|
|
BioTime CEO Dr. Michael West to Present at World Stem Cells & Regenerative Medicine Congress 2009, May 14th and Discuss New Cell Lines with Cartilage-Forming Potential |
April 30, 2009
|
|
BioTime Awarded a $4.7 Million Research Grant from the California Institute for Regenerative
Medicine |
March 23, 2009
|
|
BioTime Announces 2008 Year-End Results
|
February 26, 2009
|
|
BioTime's Subsidiary Enters Agreement Adding New Embryonic Stem Cell Lines to Its Product Portfolio
|
January 21, 2009
|
|
BioTime Launches New Stem Cell Lines in Anticipation of President Obama's Removal of Restrictions on Federal Funding of Embryonic Stem Cell Research
|
| News 2010 |
| News 2008-2007 |
| |
|
|
| |
|
|
|
|
|
|